Table 3.

Risk of adverse outcomes in the oral anticoagulant undertreatment (Non-OAC) group as compared to the guideline-directed therapy (OAC) group

	Non-OAC	OAC
	(N = 3175)	(N = 2567)	Odds ratio
Outcome	n (%)	n (%)	(95%CI)
All-cause death	154 (4.9)	34 (1.3)	3.79 (2.61–5.53)
TE events	61 (1.9)	22 (0.9)	2.28 (1.39–3.72)
Intracranial bleeding	6 (0.2)	4 (0.2)	1.22 (0.34–4.32)
Extracranial major bleeding	36 (1.1)	23 (0.9)	1.27 (0.75–2.16)

CI, confidence interval; OAC, oral anticoagulation; TE, thromboembolic.